1-[2(R)-(2-Amino-2-methylpropionylamino)-3-(1H-indol-3-yl)propionyl]-3- benzylpiperidine-3(S)-carboxylic Acid Ethyl Ester (L-163,540): A Potent, Orally Bioavailable, and Short-Duration Growth Hormone Secretagogue

This publication has 12 references indexed in Scilit:

• Repeat administration of the GH secretagogue MK-0677 increases and maintains elevated IGF-I levels in beagles
  Journal of Endocrinology, 1997
• MK-0677, a potent, novel, orally active growth hormone (GH) secretagogue: GH, insulin-like growth factor I, and other hormonal responses in beagles.
  Endocrinology, 1996
• Growth hormone therapy in elderly people: an age‐delaying drug?
  Fundamental & Clinical Pharmacology, 1996
• A Receptor in Pituitary and Hypothalamus That Functions in Growth Hormone Release
  Science, 1996
• Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue.
  Proceedings of the National Academy of Sciences, 1995
• A Novel 3-Substituted Benzazepinone Growth Hormone Secretagogue (L-692,429)
  Journal of Medicinal Chemistry, 1994
• Unidirectional Spread of Secondary Sexual Plumage Traits Across an Avian Hybrid Zone
  Science, 1993
• The Synergistic Effects of His-D-Trp-Ala-Trp-D-Phe- Lys-NH₂on Growth Hormone (GH)-Releasing Factor- Stimulated GH Release and Intracellular Adenosine 3',5'-Monophosphate Accumulation in Rat Primary Pituitary Cell Culture
  Endocrinology, 1989
• Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists
  Journal of Medicinal Chemistry, 1988
• Design, Synthesis, and Biological Activity of Peptides which Release Growth Hormone in Vitro*
  Endocrinology, 1981